THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
128,656,848
Share change
+6,320,491
Total reported value
$1,334,216,025
Put/Call ratio
36%
Price per share
$10.37
Number of holders
124
Value change
+$78,466,830
Number of buys
67
Number of sells
49

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q4 2015

As of 31 Dec 2015, THERAPEUTICSMD INC - COM (TXMD) was held by 124 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 128,656,848 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Bank of New York Mellon Corp, PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, GILDER GAGNON HOWE & CO LLC, VANGUARD GROUP INC, JPMORGAN CHASE & CO, BlackRock Fund Advisors, and BlackRock Institutional Trust Company, N.A.. This page lists 124 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.